AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 5 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $188.00
- 52-wk high
- $244.89
- High
- $189.59
- 52-wk low
- $121.06
- Low
- $185.82
- Prev close
- $189.64
- Mkt cap
- $9.89B
- P/E
- 1262.5x
- Volume
- 661.2K
- Fwd P/E
- 18.9x
- Beta
- 0.76
- P/S
- 0.2x
- P/B
- 2.4x
- Profit margin
- -0.0%
- Op margin
- +1.4%
- ROE
- -0.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MOH filings
Are insiders buying or selling Molina Healthcare Inc (MOH) stock?
Neither. Molina Healthcare Inc (MOH) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded MOH recently?
None. No member of Congress disclosed a MOH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MOH smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- DS
D.E. Shaw
$36.6M
added
Sells/Trims (2)
- MC
Maverick Capital
$86.1M
sold
- P7
Point72
$42.3M
sold
What insiders are doing
What Congress is doing
Sells (2)
How top traders are positioned
No tracked top-trader positions in MOH right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 10.2% above what analysts expected.
Earnings per share
$1.37 expected
Reports Oct 21, 2026, in 20 days
Estimates as of Sep 29, 2026
EPS expected
$0.69 to $1.68
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.48B | $11.38B | $10.80B | $10.87B |
| Cost of what it sold | $10.55B | $8.81B | $9.77B | $9.95B |
| Gross profit | $927.0M | $2.56B | $1.02B | $10.87B |
| What it spent | ||||
| Sales and admin | $729.0M | $795.0M | $779.0M | $724.0M |
| Other operating costs | $61.0M | $1.93B | $67.0M | $10.01B |
| Total operating expenses | $790.0M | $2.73B | $846.0M | $10.73B |
| What was left | ||||
| Operating profit | $137.0M | -$162.0M | $176.0M | $145.0M |
| Interest on debt | $49.0M | $52.0M | $54.0M | $54.0M |
| Profit before tax | $88.0M | -$214.0M | $29.0M | $91.0M |
| Tax | $9.0M | -$54.0M | $15.0M | $31.0M |
| Net profit | $79.0M | -$160.0M | $14.0M | $60.0M |
| EBITDA | $182.0M | -$118.0M | $122.0M | $185.0M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace